Audience for the document: Share Class: Language of the document:


Share Class: Language of the document:

Change Details

If you need to change your email address please contact us.
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price ("TRP") claims compliance with the Global Investment Performance Standards (GIPS®) and has prepared and presented this report in compliance with the GIPS standards. T. Rowe Price has been independently verified for the twenty four-year period ended June 30, 2020, by KPMG LLP. The verification report is available upon request. A firm that claims compliance with the GIPS standards must establish policies and procedures for complying with all the applicable requirements of the GIPS standards. Verification provides assurance on whether the firm’s policies and procedures related to composite and pooled fund maintenance, as well as the calculation, presentation, and distribution of performance, have been designed in compliance with the GIPS standards and have been implemented on a firm-wide basis. Verification does not provide assurance on the accuracy of any specific performance report.

TRP is a U.S. investment management firm with various investment advisers registered with the U.S. Securities and Exchange Commission, the U.K. Financial Conduct Authority, and other regulatory bodies in various countries and holds itself out as such to potential clients for GIPS purposes. TRP further defines itself under GIPS as a discretionary investment manager providing services primarily to institutional clients with regard to various mandates, which include U.S, international, and global strategies but excluding the services of the Private Asset Management group.

A complete list and description of all of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest

Please enter valid search characters

US Equities

How Large-Cap Stock Investors Can Adapt to a Slowing Economy

While caution is warranted, cyclical opportunities exist.

Joseph Fath, Portfolio Manager for the US Growth Stock Strategy
Mark S. Finn, CFA, CPA, Portfolio Manager

Key Insights

  • U.S. economic growth is slowing, but a recession is not likely in the near term.
  • Escalating trade tensions remain a risk, but durable and late‑cycle companies show promise.
  • Growth investing has significantly outperformed value investing over the past decade, but both strategies face different challenges in the current environment.

Q. How is the U.S. economic slowdown affecting large‑cap stocks?

Joe Fath: The U.S. economy is showing steady, though slow, growth. The slowdown has not yet affected companies significantly in terms of their profit and loss statements, particularly the disruptive secular growers, such as the Googles and Amazons, as well as some software-as-a-service stocks like, ServiceNow, and Workday. Also, we should be mindful that year‑over‑year comparisons will reflect the fact that the tax cuts of 2018 have begun to roll off.

The biggest weakness has been among cyclicals, but even the technology, health care, and consumer discretionary sectors—in which we have relatively higher exposures—have mostly done well. Defensive sectors—such as consumer staples, utilities, and real estate investment trusts (REITs)—and yield plays like the cell phone tower companies also have performed relatively well recently due to fears that we are in the later innings of the economic cycle coupled with a flattening or inverted interest rate yield curve.

Mark Finn: About half of the Russell 1000 Value Index is composed of companies with some level of cyclicality, including financials, energy, industrials, and materials. So an economic slowdown poses challenges for stock selection in those sectors in particular. What’s unique about this 10‑year bull market is that each time it appeared we were on the precipice of a recession, the central banks maintained their accommodative policy, so you should be cautious about getting too defensive even if you think we are near the end of the cycle. In the United States, a lot of the leading indicators are slowing, but employment has held up well. Outside the United States, developed market economies are notably more sluggish.

(Fig. 1) Global Growth Stalling
But no recession is expected near term
January 2015 to June 2019

Sources: Haver Analytics/J.P. Morgan/IHS Markit (See Additional Disclosures) and Business Roundtable.

Q. What’s the impact of rising trade tensions between the U.S. and China?

Joe Fath: For the most part, companies have been able to mitigate the tariff impact. They either made adjustments in their business model or sought concessions from suppliers. The multinational industrials have been hit the hardest along with consumer companies like Dollar Tree and other retailers that import a lot from China. But I think more companies will aim to de‑risk by moving production away from China. With the United States expanding its tariffs to Chinese consumer goods, many companies will be forced to pass along those extra costs to consumers. It’s too early to tell the long‑term ramifications to markets, but the longer these additional costs are imposed, the more they will impact market conditions. In China, internet companies Alibaba and Tencent have solid business models. But trade tensions are a headwind to consumer sentiment and demand, and not just for these successful platforms.

Mark Finn: I agree that many U.S. companies have shifted supply lines to avoid tariffs. But you can’t totally reinvent your business model and just go unplug China and plug in 10 other countries. The longer the trade war goes on, the more risk there is because companies will be forced to reduce orders and relocate manufacturing away from China, and this will be costly to their businesses and to the economy.

(Fig. 2) Historic Outperformance for Growth Over Value
Both strategies face different challenges
Cumulative Total Return, May 31, 2007, to June 30, 2019

Past performance is not a reliable indicator of future performance.

Sources: T. Rowe Price calculations using data from FactSet Research Systems Inc. (See Additional Disclosures) All rights reserved.

Q. What is your investment strategy in this environment?

Mark Finn: My bias is to quality and to be modestly defensive. Normally, at the end of a long expansion you would be tilting toward less cyclical exposure, including utilities, consumer staples, and REITs. The challenge is that the market has moved that way already. The higher-quality defensive stocks are expensive, and those with more cyclical exposure are relatively cheap. The Federal Reserve may do its best to avoid a natural slowdown or a recession. So I’ve tried to invest in cyclical stocks that offer a compelling investment case and reasonable valuation.

I am underweight financials because we are late in the credit cycle, and low interest rates are likely to compress margins. I’m underweight energy due to abundant supplies. Among cyclicals, I’m meaningfully overweight technology, where I see opportunities among semiconductors and semiconductor equipment manufacturers. Among materials, I’ve focused on some of the industrial gases that are tethered to the chemical and oil infrastructure.

Joe Fath: In the first half of this year, the defensive sectors and the high-growth sectors performed well, and the cyclicals had not really participated. So the market is generally telling you that investors are worried that we may be in the last innings of this economic expansion. But the late cyclicals are probably really attractive hunting ground now. To Mark’s point, I, too, favor some of the industrial gas companies, as they tend to do well late in the cycle. There is also opportunity in the industrial semiconductor industry, such as Texas Instruments.

Overall, my strategy looks like an upside‑down pyramid. The top sleeve is composed of secular growth names that represent 50% to 60% of the portfolio. The cyclical sleeve represents 15% to 25%. That’s where we have been doing more hunting lately. The bottom part of the pyramid, with a range of 15% to 25% consists of special situations, particularly companies exposed to industry structural change or companies pivoting from value to growth, as of the end of July 2019.

I favor companies that have more control over their destiny, are positioned to benefit from powerful secular trends, and are using innovation to disrupt less efficient business models and create new ones. I believe that firms effective at leveraging innovation will be able to sustain robust growth in earnings and revenues as they exploit new markets and seize share in existing ones. McDonald’s, for example, is undergoing a significant digital transformation that enhances the customer experience. In technology, I favor the platform business models and am underweight hardware-driven technology enterprises that tend to be more cyclical.

(Fig. 3) Slowing Growth in Corporate Earnings
S&P 500 Quarterly Earnings
Year‑Over‑Year Growth, December 31, 2012, to March 31, 2020

Source: FactSet Research Systems, Inc. (See Additional Disclosures)

Q. What about the politics swirling around the health care sector?

Mark Finn: The health care sector is facing political headwinds, such as potential limits on drug pricing and single‑payer health care initiatives, but the sector should benefit longer term from secular tailwinds, including an aging population, new technology applications, and improved treatment options.

Joe Fath: Our allocation to health care is most leveraged to select therapeutics and medical device companies—such as Intuitive Surgical and Stryker—that are utilizing technology and that we believe have limited exposure to potential regulatory pressures. I’ve avoided material exposure to pharmaceuticals and biotechnology. The pace of innovation and growth in biotechnology has slowed quite a bit, and big pharma is in the bull’s-eye of efforts to lower drug care costs. We’ve also reduced our exposure to managed care due to elevated headline risk through next year’s election as several “Medicare For All” proposals would drive existential risk to these for‑profit businesses.

Q. What is your outlook for the U.S. economy and corporate earnings?

Joe Fath: We haven’t seen the excesses that were evident in the last financial crisis, so if we have a recession, it should be more of a relatively normal recession in which gross domestic product declines by 1% to 2% over a few quarters. We’re already seeing weakening data in certain pockets, particularly transportation and manufacturing. But job growth and housing continue to look pretty good. I think we’ll see overall growth slow, but the risks of a significant U.S. or global economic downturn still appear limited.

In a slower growth environment, selectivity is key. Overall, there is a high degree of certainty that the rate of earnings growth will slow to some degree. The question is how much it affects the market’s valuation multiples. Does the market look past that, or is it a sign of more to come and multiples compress? The wild card is the 2020 presidential election. The rhetoric leading up to it could certainly affect sentiment and spur volatility.

Mark Finn: I also expect earnings growth to be more challenging, especially with the protracted trade negotiations. The U.S. economy is not going gangbusters, but it’s doing fine. The strong labor market and rising wages should continue to strengthen consumers’ balance sheets. However, the expansion may have difficulty maintaining its recent pace. A recession is definitely on the horizon, but we just don’t know how far off that is. When the labor market weakens and consumer credit suffers, that will tell you that the horizon could be very near. That’s why you need to balance your strategy between defensive and procyclical positioning.

Q. What should investors be mindful of in today’s climate?

Mark Finn: Low interest rates continue to support equities and those seeking to earn a reasonable return over time. I would not advocate that investors concerned about the end of the economic cycle sell their equity shares. You just need to be reasonably balanced in your overall investment strategy and perhaps be somewhat defensively positioned. In our strategy, we are ever diligent about the risks that companies face and how disruption is impacting companies more generally. That is really important for value investors because half the battle in value investing is avoiding value traps.

Joe Fath: As growth investors, we remain cautiously positive about U.S. equities. However, valuations are less forgiving today than at the start of 2019.

And the key risks—escalating trade disputes, the slowing economy, and political uncertainty—could trigger renewed volatility and impede market performance. As active managers, we need to be very selective and make sure we invest in companies that are well positioned and have a very good management team that can navigate through choppier waters and execute well.

Key Risks—The following risks are materially relevant to the strategy highlighted in this material: Transactions in securities of foreign currencies may be subject to fluctuations of exchange rates which may affect the value of an investment. The fund is subject to the volatility inherent in equity investing, and its value may fluctuate more than a fund investing in income-oriented securities.

Additional Disclosure
Copyright 2019 FactSet. All Rights Reserved.

Copyright ©2019, Markit Economics Limited. All rights reserved and all intellectual property rights retained by Markit Economics Limited.

Information has been obtained from sources believed to be reliable, but J.P. Morgan does not warrant its completeness or accuracy. The index is used with permission. The Index may not be copied, used, or distributed without J.P. Morgan’s prior written approval. Copyright © 2019, J.P. Morgan Chase & Co. All rights reserved.

Important Information

This material is being furnished for general informational purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, and prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. It is not intended for distribution to retail investors in any jurisdiction.

Canada—Issued in Canada by T. Rowe Price (Canada), Inc. T. Rowe Price (Canada), Inc.’s investment management services are only available to Accredited Investors as defined under National Instrument 45-106. T. Rowe Price (Canada), Inc. enters into written delegation agreements with affiliates to provide investment management services.

© 2019 T. Rowe Price. All rights reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the Bighorn Sheep design are, collectively and/or apart, trademarks of T. Rowe Price Group, Inc.

ID0002498 (08/2019)